Acadia Pharmaceuticals

Aktienkurs
23.56
Täglich Wechseln
0.10 0.43%
Monatlich
-14.08%
Jährlich
27.01%
Q1 Prognose
22.84




Ebit Veränderung Datum
Acadia Pharmaceuticals USD 35.76M 3.38M 2025-09
ALKERMES USD 89.08M 3.9M 2025-09
Alnylam Pharmaceuticals USD -29.96M 34.85M 2025-09
Biogen USD 659.6M 157M 2025-09
BioMarin Pharmaceutical USD -31.69M 308.58M 2025-09
Bristol-Myers Squibb USD 3.47B 567M 2025-12
Corcept Therapeutics USD 10.22M 16.46M 2025-09
Cytokinetics USD -166.76M 55.25M 2025-09
Eisai JPY 13.67B 7.07B 2025-09
Eli Lilly USD 8.99B 1.57B 2025-12
Incyte USD 431.31M 120.49M 2025-09
J&J USD 5.11B 2.3B 2025-12
Moderna USD -260M 557M 2025-09
Neurocrine Biosciences USD 239.3M 93.7M 2025-09
Pfizer USD 4.65B 71M 2025-12
Prothena USD -39.76M 12.25M 2025-09
PTC Therapeutics USD 3.49M 38.35M 2025-09
Sarepta Therapeutics USD -62.88M 178.46M 2025-09
Ultragenyx Pharmaceutical USD -170.89M 22.68M 2025-09
Vertex Pharmaceuticals USD 1.24B 84.6M 2025-09


Acadia Pharmaceuticals - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Feb 2026.